These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 17317897
21. Clinical profile, management, and outcome of retinoblastoma in singapore. Lim FP, Soh SY, Iyer JV, Tan AM, Swati H, Quah BL. J Pediatr Ophthalmol Strabismus; 2013; 50(2):106-12. PubMed ID: 23244241 [Abstract] [Full Text] [Related]
22. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]
23. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A. Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213 [Abstract] [Full Text] [Related]
24. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy. Ghassemi F, Rahmanikhah E, Roohipoor R, Karkhaneh R, Faegh A. Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769 [Abstract] [Full Text] [Related]
25. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Trans Am Ophthalmol Soc; 2004 Apr; 102():35-44; discussion 44-5. PubMed ID: 15747743 [Abstract] [Full Text] [Related]
26. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Friedman DL, Krailo M, Villaluna D, Gombos D, Langholz B, Jubran R, Shields C, Murphree L, O'Brien J, Kessel S, Rodriguez-Galindo C, Chintagumpala M, Meadows AT. Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28019092 [Abstract] [Full Text] [Related]
27. Conservative therapy in intraocular retinoblastoma: response/recurrence rate. Schiavetti A, Hadjistilianou T, Clerico A, Bonci E, Ragni G, Castello MA. J Pediatr Hematol Oncol; 2005 Jan; 27(1):3-6. PubMed ID: 15654270 [Abstract] [Full Text] [Related]
32. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M. J Pediatr Hematol Oncol; 2006 Jun 15; 28(6):342-5. PubMed ID: 16794500 [Abstract] [Full Text] [Related]
33. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ. Arch Ophthalmol; 1996 Nov 15; 114(11):1348-56. PubMed ID: 8906025 [Abstract] [Full Text] [Related]
34. Results of a prospective study for the treatment of unilateral retinoblastoma. Chantada GL, Fandiño AC, Guitter MR, Raslawski EC, Dominguez JL, Manzitti J, de Dávila MT, Zubizarreta P, Scopinaro M. Pediatr Blood Cancer; 2010 Jul 15; 55(1):60-6. PubMed ID: 20486172 [Abstract] [Full Text] [Related]
35. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma. Liu Y, Zhang X, Liu F, Wang KL. Asian Pac J Cancer Prev; 2014 Jul 15; 15(18):7805-9. PubMed ID: 25292067 [Abstract] [Full Text] [Related]
36. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy]. Xue K, Qian J, Yue H, Yuan YF, Zhang R. Zhonghua Yan Ke Za Zhi; 2012 Jul 15; 48(7):625-30. PubMed ID: 22943868 [Abstract] [Full Text] [Related]
37. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma. Ye H, Du Y, Chen R, Luo X, Mao Y, Ai S, Ma W, Ding Y, Li Q, Yang H. Curr Eye Res; 2016 Nov 15; 41(11):1507-1512. PubMed ID: 27158739 [Abstract] [Full Text] [Related]
38. [Retinoblastoma: preliminary results of national treatment protocol at Casablanca university medical center]. El Kettani A, Aderdour S, Daghouj G, Knari S, Zaghloul K, Zafad S, Harif M, Benchekroun S. J Fr Ophtalmol; 2014 Feb 15; 37(2):115-24. PubMed ID: 24507074 [Abstract] [Full Text] [Related]
39. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide. Varan A, Kiratli H, Aydın B, Tarlan B, Poyraz CB, Akyüz C, Büyükpamukçu M. Pediatr Hematol Oncol; 2012 Sep 15; 29(6):529-37. PubMed ID: 22759219 [Abstract] [Full Text] [Related]
40. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar 15; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]